Literature DB >> 25029600

Gene-modified cells for stem cell transplantation and cancer therapy.

Malcolm K Brenner1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25029600      PMCID： PMC4098817          DOI： 10.1089/hum.2014.2527

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  50 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Systemic inflammatory response syndrome after administration of unmodified T lymphocytes.

Authors:  Anastasia Papadopoulou; Robert A Krance; Carl E Allen; Daniel Lee; Cliona M Rooney; Malcolm K Brenner; Ann M Leen; Helen E Heslop
Journal:  Mol Ther       Date:  2014-03-21       Impact factor: 11.454

3.  Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor.

Authors:  John Maher; Renier J Brentjens; Gertrude Gunset; Isabelle Rivière; Michel Sadelain
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

4.  Rescuing US biomedical research from its systemic flaws.

Authors:  Bruce Alberts; Marc W Kirschner; Shirley Tilghman; Harold Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

5.  Monoclonal antibodies defining distinctive human T cell surface antigens.

Authors:  P Kung; G Goldstein; E L Reinherz; S F Schlossman
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

6.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

7.  Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow.

Authors:  J Z Wimperis; M K Brenner; H G Prentice; J E Reittie; P Karayiannis; P D Griffiths; A V Hoffbrand
Journal:  Lancet       Date:  1986-02-15       Impact factor: 79.321

8.  Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.

Authors:  Catherine M Bollard; Claudia Rössig; M Julia Calonge; M Helen Huls; Hans-Joachim Wagner; Joan Massague; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

9.  Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy.

Authors:  Claudia Rossig; Catherine M Bollard; Jed G Nuchtern; Cliona M Rooney; Malcolm K Brenner
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

10.  Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients.

Authors:  H G Prentice; H A Blacklock; G Janossy; M J Gilmore; L Price-Jones; N Tidman; L K Trejdosiewicz; D B Skeggs; D Panjwani; S Ball
Journal:  Lancet       Date:  1984-03-03       Impact factor: 79.321
View more
  1 in total

1.  Awakening immunity against cancer: a 2017 primer for clinicians.

Authors:  Amit Jain; Qing Zhang; Han-Chong Toh
Journal:  Chin J Cancer       Date:  2017-08-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.